These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 24215165)

  • 21. Pulsatile drug release from an insoluble capsule body controlled by an erodible plug.
    Krögel I; Bodmeier R
    Pharm Res; 1998 Mar; 15(3):474-81. PubMed ID: 9563080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
    Philip G; Pedinoff A; Vandormael K; Tymofyeyev Y; Smugar SS; Reiss TF; Korenblat PE
    J Asthma; 2010 Dec; 47(10):1078-84. PubMed ID: 20936994
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of osmotic pump-based controlled release system of Ambroxol Hydrochloride.
    Cheng X; Sun M; Gao Y; Cao F; Zhai G
    Pharm Dev Technol; 2011 Aug; 16(4):392-9. PubMed ID: 20429827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Preparation and in vitro release of tetramethylpyrazine phosphate pulsincap capsule controlled by an erodible plug].
    Wu F; Zhang ZR; He WL; Zhang Y
    Yao Xue Xue Bao; 2002 Sep; 37(9):733-8. PubMed ID: 12567902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and evaluation of osmotically controlled oral drug delivery system of glipizide.
    Verma RK; Garg S
    Eur J Pharm Biopharm; 2004 May; 57(3):513-25. PubMed ID: 15093601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium.
    Bajpai M; Singh DC; Bhattacharya A; Singh A
    Indian J Pharm Sci; 2012 Mar; 74(2):101-6. PubMed ID: 23325989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time and pH dependent colon specific, pulsatile delivery of theophylline for nocturnal asthma.
    Mastiholimath VS; Dandagi PM; Jain SS; Gadad AP; Kulkarni AR
    Int J Pharm; 2007 Jan; 328(1):49-56. PubMed ID: 16942847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a colonic release capsule dosage form and the absorption of insulin.
    Kraeling ME; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1992 Apr; 14(3):199-209. PubMed ID: 1378164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral pulsatile drug delivery systems.
    Maroni A; Zema L; Cerea M; Sangalli ME
    Expert Opin Drug Deliv; 2005 Sep; 2(5):855-71. PubMed ID: 16296783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FDC of montelukast with levocetirizine: focus on bilayer technology.
    Rathod RT; Misra D
    J Indian Med Assoc; 2009 Aug; 107(8):562-4. PubMed ID: 20112841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bioequivalence studies for two different strengths of montelukast in healthy volunteers: 10 mg film-coated tablets and 5 mg chewable tablets.
    Pedroso P; Almeida S; Filipe A; Neves RI; Boudreault S; Jiménez C
    Drug Res (Stuttg); 2013 Sep; 63(9):477-83. PubMed ID: 23780502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs.
    Niwa K; Takaya T; Morimoto T; Takada K
    J Drug Target; 1995; 3(2):83-9. PubMed ID: 7496731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evaluation of the in vitro release and in vivo absorption in rabbits of the modified-release dosage forms.
    Petrovic AA; Petricevic SM; Ristic SM; Ibric SR; Simic SS; Djuric ZR; Popovic RB
    Drug Dev Ind Pharm; 2013 Jun; 39(6):889-900. PubMed ID: 22905673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new pressure-controlled colon delivery capsule for chronotherapeutic treatment of nocturnal asthma.
    Barakat NS; Al-Suwayeh SA; Taha EI; Bakry Yassin AE
    J Drug Target; 2011 Jun; 19(5):365-72. PubMed ID: 20681754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Montelukast-loaded nanostructured lipid carriers: part I oral bioavailability improvement.
    Patil-Gadhe A; Pokharkar V
    Eur J Pharm Biopharm; 2014 Sep; 88(1):160-8. PubMed ID: 24878424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel system for three-pulse drug release based on "tablets in capsule" device.
    Li B; Zhu J; Zheng C; Gong W
    Int J Pharm; 2008 Mar; 352(1-2):159-64. PubMed ID: 18055142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
    Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
    J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions.
    Cao QR; Choi HG; Kim DC; Lee BJ
    Int J Pharm; 2004 Apr; 274(1-2):107-17. PubMed ID: 15072787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro dissolution and in vivo oral absorption of methylphenidate from a bimodal release formulation in healthy volunteers.
    Wang Y; Lee L; Somma R; Thompson G; Bakhtiar R; Lee J; Rekhi GS; Lau H; Sedek G; Hossain M
    Biopharm Drug Dispos; 2004 Mar; 25(2):91-8. PubMed ID: 14872557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [One tablet daily against asthma and allergic rhinitis].
    Krankenpfl J; 2005; 43(4-6):118. PubMed ID: 16171064
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.